Log in to save to my catalogue

Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression

Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7b2ac08bf8ed494593c19dd0b11ab84a

Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression

About this item

Full title

Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression

Publisher

England: BioMed Central Ltd

Journal title

BMC cancer, 2017-04, Vol.17 (1), p.261-261, Article 261

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

H3K27me3 histone marks shape the inhibition of gene transcription. In prostate cancer, the deregulation of H3K27me3 marks might play a role in prostate tumor progression.
We investigated genome-wide H3K27me3 histone methylation profile using chromatin immunoprecipitation (ChIP) and 2X400K promoter microarrays to identify differentially-enriched...

Alternative Titles

Full title

Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7b2ac08bf8ed494593c19dd0b11ab84a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7b2ac08bf8ed494593c19dd0b11ab84a

Other Identifiers

ISSN

1471-2407

E-ISSN

1471-2407

DOI

10.1186/s12885-017-3256-y

How to access this item